Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Choose an application
"This edited volume examines countries around the world that took seriously the Alma-Ata Declaration of 1978 and expanded their primary health care system for access by all citizens. This book makes a case for promoting population-level health through universal primary care"--
Developing Countries --- Community Health Services --- Quality Improvement --- Population Health Management --- Primary Health Care --- Alma-Ata Declaration --- PHC (Primary health care) --- Community health services --- Neighborhood health centers --- Public health --- Regional medical programs --- Medicolegal issues --- Primary health care --- Developing countries --- Health Management, Population --- Management, Population Health --- Population Health Managements --- Improvement, Quality --- Improvements, Quality --- Quality Improvements --- Emerging nations --- Fourth World --- Global South --- LDC's --- Least developed countries --- Less developed countries --- Newly industrialized countries --- Newly industrializing countries --- NICs (Newly industrialized countries) --- Third World --- Underdeveloped areas --- Underdeveloped countries --- Community health services. --- Quality Improvement. --- Population Health Management. --- Primary health care. --- Developing countries.
Choose an application
Choose an application
"This edited volume examines countries around the world that took seriously the Alma-Ata Declaration of 1978 and expanded their primary health care system for access by all citizens. This book makes a case for promoting population-level health through universal primary care"--
Primary Health Care. --- Population Health Management --- Quality Improvement. --- Community Health Services. --- Developed Countries. --- Soins de santé primaires --- Gestion de la santé de la population --- Amélioration de la qualité --- Services communautaires de santé --- Pays en voie de développement. --- Alma-Ata Declaration
Choose an application
This book summarizes current theory and evidence relating to immunization supply, demand, distribution, and financing. It provides readers with an understanding of the obstacles faced in the field, and the possible approaches to corresponding solutions.
Medical economics. --- Vaccines. --- Biologicals --- Economics, Medical --- Health --- Health economics --- Hygiene --- Medical care --- Medicine --- Economic aspects
Choose an application
Choose an application
April 2000 - Demand for AIDS vaccines varies by level of risk and by national wealth. At-risk individuals in poor countries suffer on both counts. Providing funds to develop and distribute AIDS vaccines should be a global concern. Bishai, Lin, and Kiyonga delineate two different algorithms for the purchase of AIDS vaccines, to show how differences in policy objectives can greatly affect projections of the number of courses of vaccine that will be needed. They consider a hypothetical vaccine costing USD 10 to produce, and offering 60 percent, 75 percent, and 90 percent reductions in the risk of HIV for 10 years. For each of the world's 10 major geographic divisions, they use published estimates of the risk of AIDS, the value of medical costs averted, and the value of potential productivity losses. Under the health sector algorithm - in which purchases are made to minimize the impact of AIDS/HIV on government health spending - 766 million courses of vaccine would be purchased. Under the societal algorithm - in which purchases are made to minimize the impact of AIDS/HIV on health spending and GDP - more than 3.7 billion courses of vaccine would be purchased. Under an equity model - allocating vaccines to everyone in the world at high risk as if they had the financial resources of Western Europeans - vaccine would be offered to 4.7 billion people. For a Western European man, reducing the risk of HIV/AIDS would be a USD 789 concern; in Africa, the comparable risk would be a USD 48,577 crisis. The authors conclude that financing AIDS vaccines solely on the fixed budget of a ministry of health means large vulnerable populations wouldn't receive the vaccine. Allocating the vaccine based on society's ability to pay would still exclude many poor infants who would probably be immunized if they were born in more developed regions. Policymakers concerned about equity in health care must redouble efforts to making the financing of development and distribution of AIDS vaccines a global, not a regional, concern. This paper was commissioned by the World Bank AIDS Vaccine Task Force, co-chaired by Poverty and Human Resources, Development Research Group and the Health, Nutrition, and Population Team, Human Development Network. David Bishai may be contacted at dbishai@jhsph.edu.
AIDS HIV --- Bereavement --- Children --- Disease Control and Prevention --- Drug Users --- Epidemiology --- Families --- Health Care --- Health Monitoring and Evaluation --- Health, Nutrition and Population --- Hepatitis B --- Hygiene --- Influenza --- Morbidity --- Patient --- Patients --- People --- Public Health --- Risk Groups --- Sex Workers --- Strategy --- Vaccination --- Victims --- Workers
Choose an application
Objectives: This study estimates the value that clients place on drug rehabilitation services at the time of intake and how this value varies with the probability of success and availability of social services. Methods: We interviewed 241 heroin users who had been referred to, but had not yet entered, methadone maintenance treatment in Baltimore, Maryland. We asked each subject to state a preference among three hypothetical treatment programs that varied across 3 domains: weekly fee paid by the client out of pocket ($5 to $100), presence/absence of case management, and time spent heroin-free (3 to 24 months). Each subject was asked to complete 18 orthogonal comparisons. Subsequently each subject was asked if they likely would enroll in their preferred choice among the set of three. We computed the expected willingness to pay (WTP) as the probability of enrollment times the fee considered in each choice considered from a multivariate logistic model that controlled for product attributes. We also estimated the price elasticity of demand. Results: We found that 21% of clients preferred programs that were logically dominated by other options. The median expected fee subjects were willing to pay for a program that offered 3 months of heroin-free time was $7.30 per week, rising to $17.11 per week for programs that offered 24 months of heroin-free time. The availability of case management increased median WTP by $5.64 per week. The fee was the most important predictor of the self-reported probability of enrollment with a price elasticity of -0.39 (SE 0.042). Conclusions: Clients' median willingness to pay for drug rehabilitation fell short of the average program costs of $82 per week, which reinforces the need for continued subsidization as drug treatment has high positive externalities. Clients will pay more for higher rates of treatment success and for the presence of case management.
Listing 1 - 8 of 8 |
Sort by
|